Global Immunopeptidome Profiling 麻豆原创 Research Report 2024

Publication ID:

PB512243234

Publication Date:

December 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Immunopeptidome Profiling was valued at US$ 369 million in the year 2023 and is projected to reach a revised size of US$ 644 million by 2030, growing at a CAGR of 8.5% during the forecast period.
The immunopeptidome refers to the study of all peptides presented by nucleated cells on MHC-Class I or II proteins (Major Histocompatibility Complex, also known as the major histocompatibility complex, such as the expression product of human MHC, HLA, Human Leukocyte Antigen) involved in the antigen presentation pathway, and is essential for the investigation of immunogenic epitopes in cell-mediated and humoral responses.Immunopeptidome profiling is the study of the dynamics and composition of class I and II immune peptides, enabling not only the discovery of targets for personalized cancer immunotherapy (such as neoantigens from tumor-specific mutations or tumor-associated antigens), but also contributes to new mRNA/polypeptide vaccines and immune cell therapy.
North American market for Immunopeptidome Profiling is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunopeptidome Profiling is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immunopeptidome Profiling in Vaccine Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immunopeptidome Profiling include Biognosys, Creative Dynamics Inc (Creative Proteomics), Cayman Chemical Company, Evotec, Helmholtz Munich, Bioinformatics Solutions Inc., Beijing Qinglian Baiao Biotechnology, Biotech Pack, Wininnovate Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunopeptidome Profiling, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunopeptidome Profiling.
The Immunopeptidome Profiling market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunopeptidome Profiling market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunopeptidome Profiling companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Biognosys
Creative Dynamics Inc (Creative Proteomics)
Cayman Chemical Company
Evotec
Helmholtz Munich
Bioinformatics Solutions Inc.
Beijing Qinglian Baiao Biotechnology
Biotech Pack
Wininnovate Biotechnology
Segment by Type
Type I Peptides
Type II Peptides
Segment by Application
Vaccine Development
Cancer Immunotherapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunopeptidome Profiling company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Immunopeptidome Profiling 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Type I Peptides
1.2.3 Type II Peptides
1.3 麻豆原创 by Application
1.3.1 Global Immunopeptidome Profiling 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vaccine Development
1.3.3 Cancer Immunotherapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunopeptidome Profiling 麻豆原创 Perspective (2019-2030)
2.2 Global Immunopeptidome Profiling Growth Trends by Region
2.2.1 Global Immunopeptidome Profiling 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunopeptidome Profiling Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Immunopeptidome Profiling Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Immunopeptidome Profiling 麻豆原创 Dynamics
2.3.1 Immunopeptidome Profiling Industry Trends
2.3.2 Immunopeptidome Profiling 麻豆原创 Drivers
2.3.3 Immunopeptidome Profiling 麻豆原创 Challenges
2.3.4 Immunopeptidome Profiling 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunopeptidome Profiling Players by Revenue
3.1.1 Global Top Immunopeptidome Profiling Players by Revenue (2019-2024)
3.1.2 Global Immunopeptidome Profiling Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Immunopeptidome Profiling 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Immunopeptidome Profiling Revenue
3.4 Global Immunopeptidome Profiling 麻豆原创 Concentration Ratio
3.4.1 Global Immunopeptidome Profiling 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunopeptidome Profiling Revenue in 2023
3.5 Global Key Players of Immunopeptidome Profiling Head office and Area Served
3.6 Global Key Players of Immunopeptidome Profiling, Product and Application
3.7 Global Key Players of Immunopeptidome Profiling, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunopeptidome Profiling Breakdown Data by Type
4.1 Global Immunopeptidome Profiling Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Immunopeptidome Profiling Forecasted 麻豆原创 Size by Type (2025-2030)
5 Immunopeptidome Profiling Breakdown Data by Application
5.1 Global Immunopeptidome Profiling Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Immunopeptidome Profiling Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Immunopeptidome Profiling 麻豆原创 Size (2019-2030)
6.2 North America Immunopeptidome Profiling 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immunopeptidome Profiling 麻豆原创 Size by Country (2019-2024)
6.4 North America Immunopeptidome Profiling 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunopeptidome Profiling 麻豆原创 Size (2019-2030)
7.2 Europe Immunopeptidome Profiling 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immunopeptidome Profiling 麻豆原创 Size by Country (2019-2024)
7.4 Europe Immunopeptidome Profiling 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunopeptidome Profiling 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Immunopeptidome Profiling 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immunopeptidome Profiling 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Immunopeptidome Profiling 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunopeptidome Profiling 麻豆原创 Size (2019-2030)
9.2 Latin America Immunopeptidome Profiling 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immunopeptidome Profiling 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Immunopeptidome Profiling 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunopeptidome Profiling 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Immunopeptidome Profiling 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immunopeptidome Profiling 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Immunopeptidome Profiling 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biognosys
11.1.1 Biognosys Company Details
11.1.2 Biognosys Business Overview
11.1.3 Biognosys Immunopeptidome Profiling Introduction
11.1.4 Biognosys Revenue in Immunopeptidome Profiling Business (2019-2024)
11.1.5 Biognosys Recent Development
11.2 Creative Dynamics Inc (Creative Proteomics)
11.2.1 Creative Dynamics Inc (Creative Proteomics) Company Details
11.2.2 Creative Dynamics Inc (Creative Proteomics) Business Overview
11.2.3 Creative Dynamics Inc (Creative Proteomics) Immunopeptidome Profiling Introduction
11.2.4 Creative Dynamics Inc (Creative Proteomics) Revenue in Immunopeptidome Profiling Business (2019-2024)
11.2.5 Creative Dynamics Inc (Creative Proteomics) Recent Development
11.3 Cayman Chemical Company
11.3.1 Cayman Chemical Company Company Details
11.3.2 Cayman Chemical Company Business Overview
11.3.3 Cayman Chemical Company Immunopeptidome Profiling Introduction
11.3.4 Cayman Chemical Company Revenue in Immunopeptidome Profiling Business (2019-2024)
11.3.5 Cayman Chemical Company Recent Development
11.4 Evotec
11.4.1 Evotec Company Details
11.4.2 Evotec Business Overview
11.4.3 Evotec Immunopeptidome Profiling Introduction
11.4.4 Evotec Revenue in Immunopeptidome Profiling Business (2019-2024)
11.4.5 Evotec Recent Development
11.5 Helmholtz Munich
11.5.1 Helmholtz Munich Company Details
11.5.2 Helmholtz Munich Business Overview
11.5.3 Helmholtz Munich Immunopeptidome Profiling Introduction
11.5.4 Helmholtz Munich Revenue in Immunopeptidome Profiling Business (2019-2024)
11.5.5 Helmholtz Munich Recent Development
11.6 Bioinformatics Solutions Inc.
11.6.1 Bioinformatics Solutions Inc. Company Details
11.6.2 Bioinformatics Solutions Inc. Business Overview
11.6.3 Bioinformatics Solutions Inc. Immunopeptidome Profiling Introduction
11.6.4 Bioinformatics Solutions Inc. Revenue in Immunopeptidome Profiling Business (2019-2024)
11.6.5 Bioinformatics Solutions Inc. Recent Development
11.7 Beijing Qinglian Baiao Biotechnology
11.7.1 Beijing Qinglian Baiao Biotechnology Company Details
11.7.2 Beijing Qinglian Baiao Biotechnology Business Overview
11.7.3 Beijing Qinglian Baiao Biotechnology Immunopeptidome Profiling Introduction
11.7.4 Beijing Qinglian Baiao Biotechnology Revenue in Immunopeptidome Profiling Business (2019-2024)
11.7.5 Beijing Qinglian Baiao Biotechnology Recent Development
11.8 Biotech Pack
11.8.1 Biotech Pack Company Details
11.8.2 Biotech Pack Business Overview
11.8.3 Biotech Pack Immunopeptidome Profiling Introduction
11.8.4 Biotech Pack Revenue in Immunopeptidome Profiling Business (2019-2024)
11.8.5 Biotech Pack Recent Development
11.9 Wininnovate Biotechnology
11.9.1 Wininnovate Biotechnology Company Details
11.9.2 Wininnovate Biotechnology Business Overview
11.9.3 Wininnovate Biotechnology Immunopeptidome Profiling Introduction
11.9.4 Wininnovate Biotechnology Revenue in Immunopeptidome Profiling Business (2019-2024)
11.9.5 Wininnovate Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Biognosys
Creative Dynamics Inc (Creative Proteomics)
Cayman Chemical Company
Evotec
Helmholtz Munich
Bioinformatics Solutions Inc.
Beijing Qinglian Baiao Biotechnology
Biotech Pack
Wininnovate Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.